Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16.
Wong
Y F
YF
Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Shatin, N.T.
Chung
T K
TK
Cheung
T H
TH
Lam
S K
SK
Chang
A M
AM
D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D005260:Female; D005814:Genes, Viral / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D009856:Oncogene Proteins, Viral / Q000235:genetics; D027383:Papillomaviridae / Q000235:genetics*; D050725:Papillomavirus E7 Proteins; D012097:Repressor Proteins; D014407:Tumor Cells, Cultured / Q000187:drug effects; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000821:virology*
C068651:E6 protein, Human papillomavirus type 16; D016376:Oligonucleotides, Antisense; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D012097:Repressor Proteins; C059731:oncogene protein E7, Human papillomavirus type 16